Poly(t-butylmethacrylate) with the optimal molecular-weight characteristics (M n = 12,400; MW/M n = 1.35) for biocompatible polymers was synthesized by radical polymerization in the presence of thioglycolic acid as a chain transfer agent. The obtained polymer was converted by acid hydrolysis into a water-soluble copolymer of t-butylmethacrylate and methacrylic acid of 20:80 mass%, respectively. The copolymer of t-butylmethacrylate and methacrylic acid was modified with folic acid, which has affinity for tumor cells. A conjugate of the copolymer with doxorubicin and also a conjugate containing folate vector were synthesized. Their formation was proved using IR and UV spectroscopy.
Similar content being viewed by others
References
S. A. Protsenko, Prakt. Onkol., 8(4), 175 – 181 (2007).
A. A. Gabizon, Liposomal Drug Carriers in Cancer Therapy, in: Carriers, V. P. Torchilin (ed.), Imperial College Press, London (2006), pp. 437 – 462.
Q. Wang, X. Xie, X. Zhang, et al., Int. J. Biol. Macromol., 46, 356 – 362 (2010).
M. K. Bayazit, L. S. Clarke, K. S. Coleman, and N. Clarke, J. Am. Chem. Soc., 132, 15814 – 15819 (2010).
N. Zhang, R. Li, L. Zhang, et al., Soft Matter, 7, 7231 – 7329 (2011).
J. Shen, B. Yan, T. Li, et al., Soft Matter, 8, 1831 – 1836 (2012).
M. J. McGann, C. L. Higginbotham, L. M. Geever, and M. J. D. Nugent, Int. J. Pharm., 372, 154 – 161 (2009).
S. P. Jin and G. R. Yue, Chin. J. Appl. Chem., 29, 166 – 173 (2012).
N. A. Plate and A. E. Vasil’ev, Physiologically Active Polymers [in Russian], Khimiya, Moscow (1986).
J. O. Kim, N. V. Nukolova, A. V. Kabanov, and T. K. Bronich, Vysokomol. Soedin., Ser. A, 51(6), 1 – 11 (2009).
Y. Bae, T. A. Diezi, A. Zhao, and G. S. Kwon, J. Controlled Release, 122, 324 – 330 (2007).
M. L. Adam, A. Lavasanifar, and G. S. Kwon, J. Pharm. Sci., 92, 1343 – 1355 (2003).
G. Gaucher, R. H. Marchessault, and J. C. Leroux, J. Controlled Release, 143(1), 2 – 12 (2010).
N. Nishiyama and K. Kataoka, Pharmacol. Ther., 112(3), 630 – 648 (2006).
S. Gelperina, A. S. Khalansky, I. N. Skidan, et al., Toxicol. Lett., 126(2), 131 – 141 (2002).
E. V. Tazina, E. V. Ignat’ev, A. P. Polozkova, et al., Khim.-farm. Zh., 42(12), 33 – 35 (2008); Pharm. Chem. J., 42(12), 703 – 707 (2008).
O. O. Maksimenko, E. P. Pavlov, E. G. Tushov, et al., Khim.-farm. Zh., 42(6), 52 – 56 (2008); Pharm. Chem. J., 42(6), 363 – 367 (2008).
R. Duncan, Nat. Rev. Cancer, 6(9), 688 – 701 (2006).
C. Li and S.Wallace, Adv. Drug Delivery Rev., 60(8), 886 – 898 (2008).
F. Greco and M. J. Vicent, Front. Biosci., 13, 2744 – 2756 (2008).
Z. Xu, M. Guo, H. Yan, and K. Liu, React. Funct. Polym., 73, 564 – 572 (2013).
H. Ringsdorf, J. Polym. Sci., Polym. Symp., 51, 135 – 153 (1975).
Y. J. Gu, J. Cheng, J. Jin, et al., Int. J. Nanomed., 6, 2889 – 2898 (2011).
R. Chouhan and A. K. Bajpai, J. Nanobiotechnol., 7:3 (2009); doi: 10.1186/1477-3155-7-45.
B. Manocha and A. Margaritis, J. Nanomater., 780171 (2010); doi: 10.1155/2010/780171.
P. Yousefpour, F. Atyabi, E. Farahani, et al., Int. J. Nanomed., 6, 1487 – 1496 (2011).
Z. Liu, X. Sun, N. Nakayama-Ratchford, and H. Dai, ACS Nano, 1(1), 50 – 56 (2007).
R. J. Sturgeon and S. G. Schulman, J. Pharm. Sci., 66, 958 – 961 (1977).
M. D. Salazar and M. Ratnam, Cancer Metastasis Rev., 26, 141 – 152 (2007).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 48, No. 12, pp. 46 – 50, December, 2014.
Rights and permissions
About this article
Cite this article
Zhukova, O.V., Bulgakova, S.A. Synthesis of a Polymeric Doxorubicin Derivative and its Evaluation Using IR and UV Spectroscopy. Pharm Chem J 48, 830–834 (2015). https://doi.org/10.1007/s11094-015-1204-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-015-1204-1